Cell子刊：胚胎和干细胞来源的血小板具有更强的再生和发育潜能

Core Viewpoint - The study published in Cell Reports Medicine highlights that embryonal and stem cell-derived platelets exhibit enhanced regenerative and developmental potential compared to adult platelets, suggesting new avenues for customized platelet therapies to meet specific clinical needs [4][9]. Group 1: Research Findings - The research team conducted transcriptomic and proteomic analyses of mouse embryonic platelets, revealing that embryonic platelets show reduced classical immune regulation and coagulation features but enhanced developmental characteristics compared to adult platelets [6]. - Embryonic platelets interact more actively with various cell types, such as fibroblasts, significantly accelerating the healing of difficult wounds [6]. - Mechanistically, embryonic platelets promote fibroblast proliferation by releasing higher levels of insulin-like growth factor-2 (IGF2) [6]. Group 2: Unique Platelet Subpopulations - A specific subpopulation of CD59(a)+ platelets, which shares functional similarities with embryonic platelets, was identified in both mice and humans [7]. - Platelets derived from human induced pluripotent stem cells (hiPSCs) exhibit molecular and functional characteristics similar to those of embryonic platelets [7]. Group 3: Implications for Clinical Applications - The unique multi-omics characteristics and superior regenerative potential of embryonic and hiPSC-derived platelets provide a new direction for the development of customized platelet therapies tailored to specific clinical needs [9].